Clinuvel Pharmaceuticals (CLVLF) was downgraded to a Hold Rating at MorgansTip Ranks·Aug 31 at 12:35 AMCUVL-7.31%
Analysts Offer Insights on Healthcare Companies: Polynovo (OtherCALZF), Clinuvel Pharmaceuticals (OtherCLVLF) and Impedimed Limited (OtherIPDQF)businessinsider·Aug 28 at 05:45 AMCUVL-7.31%
Clinuvel Pharmaceuticals shares are trading lower after the company reported weak FY26 financial results.benzinga_article·Aug 27 at 02:17 PMCUVL-7.31%
12 Information Technology Stocks Moving In Thursday's Pre-Market Sessionbenzinga_article·Aug 27 at 12:05 PMAIXI-1.24%HPQ-4.50%
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga_article·Aug 27 at 12:05 PMACIU-2.80%VNRX-4.95%
Clinuvel posts FY2026 net profit after tax of A$34 million, cash reserves rise to A$252 millionPUBT·Aug 27 at 02:48 AMCUVL-7.31%
CUV: Second year of A$100m+ revenue, strong U.S. expansion, and robust cash reservesQuartr·Aug 27 at 02:46 AM
CUV: Profit streak continues with robust cash reserves and stable dividend, supporting U.S. growthQuartr·Aug 27 at 02:44 AM
A decade of profitability provides foundation for CLINUVEL’s U.S. expansion | CUVL Stock NewsStockTitan·Aug 26 at 09:42 PMCUVL-7.31%
Clinuvel flags superior release profile in VLRX-L injectable peptide platform studyPUBT·Aug 12 at 02:24 AMCUVL-7.31%
Clinuvel benchmarks vitiligo market as JAK inhibitor efficacy challenges NB-UVB standard of carePUBT·Jul 30 at 12:59 AMCUVL-7.31%
